Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Salerno

80 clinical trials in Salerno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Salerno at a glance
80
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

80 trials in Salerno

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:SELTOREXANT
  • Sponsor:Janssen - Cilag International

Coeliac disease

Recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Novartis Pharma AG
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Emrusolmin
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acp-204 Tartrate
  • Sponsor:Acadia Pharmaceuticals Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Salerno

What the registry says about research in the country

01 Hematologic Disorders

Groundbreaking trials focusing on leukemia treatments, including studies of innovative therapies for Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia. Research evaluates novel drug combinations and targeted therapies to improve patient outcomes.

  • Acute B-cell Lymphoblastic Leukemia
  • Follicular Lymphoma
  • Thrombotic Microangiopathy

Multiple studies are exploring treatment options for patients with various blood disorders, particularly focusing on those requiring stem cell transplantation.

02 Neurological Conditions

Clinical research targeting complex neurological disorders, with particular emphasis on Multiple System Atrophy and Progressive Supranuclear Palsy. Studies evaluate new therapeutic approaches for managing neurodegenerative conditions.

  • Alzheimer's Disease Psychosis
  • Major Depressive Disorder

Innovative treatments are being tested to address both motor symptoms and cognitive aspects of these challenging conditions.

03 Cardiovascular and Inflammatory Diseases

Research initiatives examining treatments for cardiovascular disease and inflammatory conditions. Studies include evaluation of new therapies for Sjögren's Syndrome and Lupus Nephritis.

  • Eosinophilic Esophagitis
  • Severe Asthma
  • Stroke Prevention

Trials focus on developing targeted treatments and improving patient outcomes across various inflammatory and cardiovascular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.